首页> 外文期刊>Pharmacognosy Research >Annonacin Exerts Antitumor Activity through Induction of Apoptosis and Extracellular Signal-regulated Kinase Inhibition
【24h】

Annonacin Exerts Antitumor Activity through Induction of Apoptosis and Extracellular Signal-regulated Kinase Inhibition

机译:Annonacin通过诱导细胞凋亡和细胞外信号调节的激酶抑制作用发挥抗肿瘤活性。

获取原文
           

摘要

Background: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries. Annonacin, a natural pure compound extracted from the seeds of Annona muricata , is a potential alternative therapeutic agent to treat EC. Objective: To study the antitumor activity of annonacin and its mechanism of action in EC cells (ECCs). Materials and Methods: Viability of ECCs treated with annonacin for 72 h was determined using methyl thiazolyl tetrazolium assay. The induction of cell cycle arrest and apoptotic cell death was evaluated using propidium iodide and annexin V-PE/7-AAD assay, respectively. DNA strand breaks were visualized using transferase dUTP nick end labeling assay, and the effects of annonacin on survival signaling were determined using western blotting. Results: Annonacin exhibited antiproliferative effects on EC cell lines (ECC-1 and HEC-1A) and primary cells (EC6-ept and EC14-ept) with EC50values ranging from 4.62 to 4.92 μg/ml. EC cells were shown arrested at G2/M phase after treated with 4 μg/ml of annonacin for 72 h. This led to a significant increase in apoptotic cell death (65.7%) in these cells when compared to vehicle-treated cells ( P Conclusion: Annonacin may be a potential novel therapeutic agent for EC patients. SUMMARY We aimed to study the antitumor activity of annonacin and its mechanism of action in endometrial cancer cells. Annonacin exerted antiproliferation effects on both endometrial cancer cell lines and primary cells via induction of apoptosis and inhibition of extracellular signal-regulated kinase. Our data represented that annonacin could be an alternative therapeutic treatment to combat endometrial cancer. Abbreviations Used: 7-AAD: 7-Amino-Actinomycin, ATP: Adenosine diphosphate, BSA: Bovine serum albumin, DNA: Deoxyribonucleic acid, EC: Endometrial cancer, ECC-1: Endometrial cancer cell-1, EC50: Half maximal effective concentration, Ept: Epithelial, FBS: Fetal bovine serum, HEC-1A: Human endometrial carcinoma-1A, MTT: Methyl thiazolyl tetrazolium, NaCl: Sodium chloride, NADH: Nicotinamide adenine dinucleotide, RPMI 1640: Roswell Park Memorial Institute Medium, SDS: Sodium dodecyl sulfate Key words: Annona muricata , apoptosis, caspase-3, cell cycle arrest, extracellular signal-regulated kinase, uterine cancer
机译:背景:子宫内膜癌(EC)是发达国家中最常见的妇科恶性肿瘤。 Annonacin是一种从纯种Annona muricata种子中提取的天然纯化合物,是治疗EC的潜在替代治疗剂。目的:研究Annnonacin在EC细胞(ECCs)中的抗肿瘤活性及其作用机制。材料和方法:使用甲基噻唑基四唑鎓测定法确定用番农酮处理72小时的ECC的活力。分别使用碘化丙啶和膜联蛋白V-PE / 7-AAD测定法评估诱导细胞周期停滞和凋亡细胞死亡。使用转移酶dUTP缺口末端标记测定法可视化DNA链断裂,并使用Western印迹法确定花农苷对存活信号的影响。结果:Annonacin对EC细胞系(ECC-1和HEC-1A)和原代细胞(EC6-ept和EC14-ept)具有抗增殖作用,EC 50 值范围为4.62至4.92μg/ ml 。 EC细胞显示在用4μg/ ml的壬南素处理72 h后停在G2 / M期。与媒介物处理的细胞相比,这导致这些细胞的凋亡性细胞死亡显着增加(65.7%)(P结论:Annonacin可能是EC患者的一种潜在的新型治疗剂。总结我们旨在研究Annonacin的抗肿瘤活性Annonacin通过诱导细胞凋亡和抑制细胞外信号调节激酶,对子宫内膜癌细胞系和原代细胞均具有抗增殖作用,我们的数据表明,Annonacin可能是对抗子宫内膜癌的另一种治疗方法。所用的缩写:7-AAD:7-氨基放线菌素,ATP:二磷酸腺苷,BSA:牛血清白蛋白,DNA:脱氧核糖核酸,EC:子宫内膜癌,ECC-1:子宫内膜癌细胞1,EC50:最大值的一半有效浓度,Ept:上皮,FBS:胎牛血清,HEC-1A:人子宫内膜癌-1A,MTT:甲基噻唑基四唑,NaCl:氯化钠,NADH:烟酰胺腺嘌呤二核苷酸,RPMI 1640:Roswell Park Memorial Institute培养基,SDS:十二烷基硫酸钠关键词:紫花番荔枝,细胞凋亡,caspase-3,细胞周期阻滞,细胞外信号调节激酶,子宫癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号